Kamari Lassiter


Age: 21
Free Agency: 2028 (UFA)
Accrued Seasons: 0
  • 2024 Salary Cap Charge: $1,639,054 (0.63% of cap)
  • 2024 Cash Payout: $4,171,212 (1.37% of spending)
  • 2024 Cash to Cap Ratio: 2.54
  • Contract Value: $9,014,800 ($2,253,698 APY)
  • Fully Guaranteed Money: $7,090,508
  • Contract Ranking: 65/343 at CB

Current Contract

(Drafted, signed 2024)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated Signing BonusGuaranteed SalaryCap
Cap %
Dead Money & Cap Savings

Contract Notes

Kamari Lassiter signed a 4 year rookie contract with the Houston Texans on May 10, 2024 worth $9,014,800 with $7,090,508 full guaranteed including a $3,376,216 signing bonus.

Cash Flows

- old money
- fully earned money
- unearned or partially earned money
Old Money2024202520262027
Cash Due$10$4,171,212$1,204,763$1,614,526$2,024,289
Running Cash$4,171,222$5,375,985$6,990,511$9,014,800
Career Earnings: $3,376,212
Career APY: $0
Potential Earnings: $9,014,790
Total Guarantees: $7,090,508
Largest Cash Payment: $4,171,212 (2024)
Largest Cap Number: $2,868,346 (2027)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money


No statistics available.

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Injury Adjusted$0$0
OTC Valuation $3.1M $6.3M $9.4M $12.5M $15.7M APY $3.5M $7M $10.5M $14M $17.5M $4,180,000 $3,576,437

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.